Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Meningococcal disease
Varicella
NITAG documentation
SAGE documentation
2014
Clear all
Type of publications
NITAG documentation
(14)
SAGE documentation
(1)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(1)
Topics
Background paper
(4)
Recommendation
(8)
Available to download in languages
English (EN)
(9)
French (FR)
(8)
Spanish (ES)
(1)
Regions
Americas
(6)
Europe
(7)
Western Pacific
(1)
Countries
Diseases
Meningococcal disease
(13)
Varicella
(2)
Diphtheria
(4)
Haemophilus influenzae type B
(1)
Hepatitis A
(2)
Hepatitis B
(2)
Human papillomavirus (HPV)
(17)
Measles
(1)
Pertussis
(7)
Pneumococcal disease
(5)
Poliomyelitis
(3)
Rotavirus
(2)
Tetanus
(1)
Typhoid
(1)
Yellow fever
(1)
Vaccine topics
Target population
Publication date
2014
(15)
2024
(1)
2023
(4)
2022
(20)
2021
(1)
2020
(1)
2019
(16)
2018
(12)
2017
(5)
2016
(12)
2015
(14)
2013
(6)
2012
(2)
2011
(6)
2010
(11)
2009
(4)
2008
(2)
2007
(4)
2006
(6)
2005
(3)
2001
(1)
2000
(1)
1997
(1)
15 results found
2014
∙
ATAGI
Advice for immunisation providers regarding the use of Bexsero® – a recombinant multicomponent meningococcal B vaccine (4CMenB)
2014
∙
NACI
Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine
2014
∙
Jessica MacNeil
Epidemiology of Serogroup B Meningococcal Disease
2014
∙
JCVI
JCVI position statement on use of Bexsero® meningococcal B vaccine in the UK
2014
∙
NACI
Literature review on serogroup B invasive meningococcal disease
2014
∙
Haut Conseil de la santé publique
Notice relating to adapting the immunisation strategy against invasive serogroup C meningococcal infections when facing a vaccine shortage
2014
∙
Haut Conseil de la santé publique
Notice relating to the immunisation schedule with the MenBvac® vaccine and to the potential revaccination with Bexsero®
2014
∙
Haut Conseil de la santé publique
Notice relating to the need to purse immunisation campaigns against clone B :14 :P1.7,16 in the French Departments of Seine-Maritime, Somme and Pyrénées-Atlantiques
2014
∙
Haut Conseil de la santé publique
Notice Update to the notice relating to antibiotic prophylaxis and meningococcal vaccination of persons treated with eculizumab (Soliris® 300mg concentrate for solution for infusion)
2014
∙
Haut Conseil de la santé publique
Notice Update to the notice relating to antibiotic prophylaxis and meningococcal vaccination of persons treated with eculizumab (Soliris® 300mg concentrate for solution for infusion)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register